- 英文名称
- 3,4,5-Tricaffeoylquinic acid
- 分子式
- C34H30O15
- 分子量
- 678.59
- 中文别名
- 3,4,5-三咖啡酰奎尼酸; 5-三咖啡酰奎宁酸; (1S,3R,4S,5R)-3,4,5-三(((E)-3-(3,4-二羟基苯基)丙烯酰基)氧基)-1-羟基环己烷-1-羧酸; (1alpha,3R,4alpha,5R)-3,4,5-Tris[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1-hydroxycyclohexanecarboxylic acid; (3R,5R)-3,4,5-tris[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1-hydroxycyclohexane-1-carboxylic acid; 3,4,5-Tri-O-caffeoylquinic acid; 3,4,5-Tricaffeoylquinic cid; Cyclohexanecarboxylic acid, 3,4,5-tris[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1-hydroxy-, (1α,3R,4α,5R)-; 5-Tricaffeoylquinic acid; (1S,3R,4S,5R)-3,4,5-Tris(((E)-3-(3,4-dihydroxyphenyl)acryloyl)oxy)-1-hydroxycyclohexane-1-carboxylic acid; 3,4,5-tricaffeoylquinic acid; 3,4,5-tri-CQA; Caffeoylquinic acid der.; (3R,5R)-3,4,5-Tris{[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoyl]oxy}-1-hydroxycyclohexanecarboxylic acid
- 用途
- 3,4,5-三咖啡酰奎宁酸通过抑制Akt和NF-κB途径抑制肿瘤坏死因子-α刺激角质形成细胞中炎性介质的产生；诱导人神经干细胞G0/G1细胞周期阻滞、肌动蛋白骨架组织、染色质重塑、神经元分化和骨形态发生蛋白信号传导；在衰老相关疾病的研究中具有潜在应用前景。
